SKYE
Price:
$1.21
Market Cap:
$38.77M
Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. was founded in 2012 and is headquartered in San Diego, California.
Industry
Biotechnology
IPO Date
2014-11-26
Stock Exchange
NASDAQ
Ticker
SKYE
According to Skye Bioscience, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 15.30M. This represents a change of -78.82% compared to the average of 72.26M of the last 4 quarters.
The mean historical Enterprise Value of Skye Bioscience, Inc. over the last ten years is 17.59M. The current 15.30M Enterprise Value has changed 8.60% with respect to the historical average. Over the past ten years (40 quarters), SKYE's Enterprise Value was at its highest in in the March 2024 quarter at 318.53M. The Enterprise Value was at its lowest in in the March 2018 quarter at 2.33M.
Average
17.59M
Median
11.48M
Minimum
4.56M
Maximum
52.09M
Discovering the peaks and valleys of Skye Bioscience, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.04%
Maximum Annual Enterprise Value = 52.09M
Minimum Annual Increase = -89.36%
Minimum Annual Enterprise Value = 4.56M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 35.30M | 57.47% |
| 2023 | 22.42M | 158.42% |
| 2022 | 8.67M | -39.30% |
| 2021 | 14.29M | 73.05% |
| 2020 | 8.26M | -48.32% |
| 2019 | 15.98M | -69.32% |
| 2018 | 52.09M | 1.04% |
| 2017 | 4.56M | -19.32% |
| 2016 | 5.66M | -34.49% |
| 2015 | 8.64M | -89.36% |
The current Enterprise Value of Skye Bioscience, Inc. (SKYE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
22.13M
5-year avg
17.79M
10-year avg
17.59M
Skye Bioscience, Inc.’s Enterprise Value is less than Aligos Therapeutics, Inc. (26.21M), greater than Xilio Therapeutics, Inc. (-57598257.00), less than Mersana Therapeutics, Inc. (83.22M), less than INmune Bio, Inc. (23.33M), greater than X4 Pharmaceuticals, Inc. (6.31M), less than Kezar Life Sciences, Inc. (20.85M), greater than Barinthus Biotherapeutics plc (-33263316.00), less than LAVA Therapeutics N.V. (19.39M), greater than PDS Biotechnology Corporation (-26077209422.00), less than CEL-SCI Corporation (51.39M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 26.21M | $62.09M | |
| -57598257.00 | $38.90M | |
| 83.22M | $137.32M | |
| 23.33M | $49.98M | |
| 6.31M | $43.35M | |
| 20.85M | $45.77M | |
| -33263316.00 | $29.44M | |
| 19.39M | $45.77M | |
| -26077209422.00 | $43.78M | |
| 51.39M | $43.22M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Skye Bioscience, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Skye Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Skye Bioscience, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Skye Bioscience, Inc. (SKYE)?
What is the 3-year average Enterprise Value for Skye Bioscience, Inc. (SKYE)?
What is the 5-year average Enterprise Value for Skye Bioscience, Inc. (SKYE)?
How does the current Enterprise Value for Skye Bioscience, Inc. (SKYE) compare to its historical average?